Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann M Bode

Showing results (31-40 of 339) with videos related to

Pageof 34
Sort By:
European Journal of Pharmacology|August 1, 2021
ACSL family: The regulatory mechanisms and therapeutic implications in cancerJing Quan, Ann M Bode, Xiangjian Luo
Nature Reviews. Cancer|February 18, 2011
Molecular targets of phytochemicals for cancer preventionKi Won Lee, Ann M Bode, Zigang Dong
NPJ Precision Oncology|June 7, 2018
Addressing the challenges of applying precision oncologySeung Ho Shin, Ann M Bode, Zigang Dong
NPJ Precision Oncology|March 27, 2019
The PGC-1/ERR network and its role in precision oncologyHumberto De Vitto, Ann M Bode, Zigang Dong
NPJ Precision Oncology|June 7, 2018
Precision medicine: the foundation of future cancer therapeuticsSeung Ho Shin, Ann M Bode, Zigang Dong
Cancer Prevention Research (Philadelphia, Pa.)|October 28, 2010
Breaking the NF-κB and STAT3 alliance inhibits inflammation and pancreatic tumorigenesisYoung-Joon Surh, Ann M Bode, Zigang Dong
Carcinogenesis|July 17, 2012
Regulatory mechanisms and clinical perspectives of miRNA in tumor radiosensitivityLuqing Zhao, Ann M Bode, Ya Cao, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 10, 2016
The epithelial-mesenchymal transition (EMT) is regulated by oncoviruses in cancerXue Chen, Ann M Bode, Zigang Dong, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|November 18, 2023
Metabolic reprogramming in nasopharyngeal carcinoma: Mechanisms and therapeutic opportunitiesQian Liu, Ann M Bode, Xue Chen, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|August 7, 2024
Unlocking the potential: Targeting metabolic pathways in the tumor microenvironment for Cancer therapySiyuan Jia, Ann M Bode, Xue Chen, et al.
Pageof 34

Showing results (31-40 of 339) with videos related to

Sort By:
Pageof 34
European Journal of Pharmacology|August 1, 2021
ACSL family: The regulatory mechanisms and therapeutic implications in cancerJing Quan, Ann M Bode, Xiangjian Luo
Nature Reviews. Cancer|February 18, 2011
Molecular targets of phytochemicals for cancer preventionKi Won Lee, Ann M Bode, Zigang Dong
NPJ Precision Oncology|June 7, 2018
Addressing the challenges of applying precision oncologySeung Ho Shin, Ann M Bode, Zigang Dong
NPJ Precision Oncology|March 27, 2019
The PGC-1/ERR network and its role in precision oncologyHumberto De Vitto, Ann M Bode, Zigang Dong
NPJ Precision Oncology|June 7, 2018
Precision medicine: the foundation of future cancer therapeuticsSeung Ho Shin, Ann M Bode, Zigang Dong
Cancer Prevention Research (Philadelphia, Pa.)|October 28, 2010
Breaking the NF-κB and STAT3 alliance inhibits inflammation and pancreatic tumorigenesisYoung-Joon Surh, Ann M Bode, Zigang Dong
Carcinogenesis|July 17, 2012
Regulatory mechanisms and clinical perspectives of miRNA in tumor radiosensitivityLuqing Zhao, Ann M Bode, Ya Cao, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 10, 2016
The epithelial-mesenchymal transition (EMT) is regulated by oncoviruses in cancerXue Chen, Ann M Bode, Zigang Dong, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|November 18, 2023
Metabolic reprogramming in nasopharyngeal carcinoma: Mechanisms and therapeutic opportunitiesQian Liu, Ann M Bode, Xue Chen, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|August 7, 2024
Unlocking the potential: Targeting metabolic pathways in the tumor microenvironment for Cancer therapySiyuan Jia, Ann M Bode, Xue Chen, et al.
Pageof 34